LATITUDE Programming System
FDA premarket approval P910077/S193 · decided 2024-04-30
Approval details
- PMA number
- P910077
- Supplement
- S193
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- LATITUDE Programming System
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2024-01-31
- Decision date
- 2024-04-30
- Days to decision
- 90 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- a software maintenance release for updates to the Model 3300 LATITUDETM Programming System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.